LUC00012I2 - - Google Patents
Info
- Publication number
- LUC00012I2 LUC00012I2 LU00012C LUC00012C LUC00012I2 LU C00012 I2 LUC00012 I2 LU C00012I2 LU 00012 C LU00012 C LU 00012C LU C00012 C LUC00012 C LU C00012C LU C00012 I2 LUC00012 I2 LU C00012I2
- Authority
- LU
- Luxembourg
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69192005P | 2005-06-17 | 2005-06-17 | |
| EP06785127A EP1909819A4 (fr) | 2005-06-17 | 2006-06-19 | Antagonistes de recepteur pour le traitement de cancer osseux metastatique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| LUC00012I1 LUC00012I1 (fr) | 2017-04-06 |
| LUC00012I2 true LUC00012I2 (fr) | 2017-06-19 |
Family
ID=37571297
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU00012C LUC00012I2 (fr) | 2005-06-17 | 2017-04-05 |
Country Status (21)
| Country | Link |
|---|---|
| US (3) | US8128929B2 (fr) |
| EP (4) | EP2100614B8 (fr) |
| JP (4) | JP2009501141A (fr) |
| KR (3) | KR101246428B1 (fr) |
| CN (3) | CN101613409B (fr) |
| BR (2) | BRPI0622073A8 (fr) |
| CA (3) | CA2612449A1 (fr) |
| CY (3) | CY1114603T1 (fr) |
| DK (2) | DK2100614T3 (fr) |
| ES (2) | ES2435727T3 (fr) |
| HK (1) | HK1135917A1 (fr) |
| HU (1) | HUS1700015I1 (fr) |
| IL (3) | IL188151A0 (fr) |
| LT (1) | LTC2100614I2 (fr) |
| LU (1) | LUC00012I2 (fr) |
| NL (1) | NL300869I2 (fr) |
| PL (2) | PL2100618T3 (fr) |
| PT (2) | PT2100614E (fr) |
| RU (3) | RU2008101772A (fr) |
| SI (2) | SI2100614T1 (fr) |
| WO (1) | WO2006138729A2 (fr) |
Families Citing this family (119)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101246428B1 (ko) * | 2005-06-17 | 2013-03-21 | 필라델피아 헬스 앤드 에듀케이션 코포레이션 디/비/에이 드렉셀 유니버시티 컬리지 오브 메디슨 | 항－ＰＤＧＦＲα 항체를 이용하여 이차 골 종양을 치료하는 방법 |
| KR101353706B1 (ko) * | 2006-02-03 | 2014-02-18 | 유니버시티 오브 워싱톤 | 전립선 암 치료용 보강제로서의 ⅰｇｆ-ⅰｒ 길항제 |
| CL2007002225A1 (es) * | 2006-08-03 | 2008-04-18 | Astrazeneca Ab | Agente de union especifico para un receptor del factor de crecimiento derivado de plaquetas (pdgfr-alfa); molecula de acido nucleico que lo codifica; vector y celula huesped que la comprenden; conjugado que comprende al agente; y uso del agente de un |
| CL2008001071A1 (es) * | 2007-04-17 | 2009-05-22 | Smithkline Beecham Corp | Metodo para obtener anticuerpo penta-especifico contra il-8/cxcl8, gro-alfa/cxcl1, gro-beta/cxcl2), gro-gama/cxcl3 y ena-78/cxcl5 humanas; anticuerpo penta-especifico; proceso de produccion del mismo; vector, hbridoma o celela que lo comprende; composicion farmceutica; uso para tratar copd, otras enfermedades. |
| WO2009021150A2 (fr) | 2007-08-08 | 2009-02-12 | California Pacific Medical Center | Le récepteur du facteur de croissance dérivés des plaquettes tolère l'infectiosité du cytomégalovirus |
| EP2205280B1 (fr) | 2007-09-27 | 2019-09-04 | Amgen Inc. | Formules pharmaceutiques |
| US8796206B2 (en) | 2007-11-15 | 2014-08-05 | Amgen Inc. | Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration |
| US20090280112A1 (en) * | 2008-05-05 | 2009-11-12 | The Regents Of The University Of California | Inhibitory effects of nordihydroguaiaretic acid (ndga) on the igf-1 receptor and androgen dependent growth of lapc-4 prostate cancer cells |
| TW201000119A (en) * | 2008-06-10 | 2010-01-01 | Oncotherapy Science Inc | MYBL2 epitope peptides and vaccines containing the same |
| MX344382B (es) | 2009-10-23 | 2016-12-14 | Amgen Inc * | Adaptador de vial y sistema. |
| MX2012014180A (es) | 2010-06-07 | 2013-05-06 | Amgen Inc | Dispositivo de administracion de farmacos. |
| JP2013177317A (ja) * | 2010-06-24 | 2013-09-09 | Meneki Seibutsu Kenkyusho:Kk | 抗ｐｄｇｆ受容体抗体 |
| WO2012003470A2 (fr) * | 2010-07-02 | 2012-01-05 | Medimmune, Llc | Formulations d'anticorps |
| EP2671082B1 (fr) | 2011-02-02 | 2020-01-15 | Amgen Inc. | Méthodes et compositions associées à l'inhibition d'igf-1r |
| MX341790B (es) | 2011-03-31 | 2016-09-02 | Amgen Inc | Adaptador de viales y sistema. |
| DK2699293T3 (en) | 2011-04-20 | 2019-04-29 | Amgen Inc | AUTO INJECTION DEVICE |
| MX2014002289A (es) | 2011-08-26 | 2015-03-20 | Merrimack Pharmaceuticals Inc | Anticuerpos fc especificos en tandem. |
| ES2923766T3 (es) | 2011-10-14 | 2022-09-30 | Amgen Inc | Inyector y método de montaje |
| CA2852127C (fr) | 2011-11-11 | 2020-10-27 | Duke University | Polytherapie medicamenteuse pour le traitement de tumeurs solides |
| US8980259B2 (en) | 2012-07-20 | 2015-03-17 | Novartis Ag | Combination therapy |
| EP4234694A3 (fr) | 2012-11-21 | 2023-09-06 | Amgen Inc. | Dispositif d'administration de médicaments |
| CA2941010A1 (fr) | 2013-02-26 | 2014-09-04 | Triact Therapeutics, Inc. | Cancerotherapie |
| CA2902505A1 (fr) | 2013-03-06 | 2014-09-12 | Merrimack Pharmaceuticals, Inc. | Anticorps bispecifiques anti-c-met a fc en tandem |
| TWI580452B (zh) | 2013-03-15 | 2017-05-01 | 安美基公司 | 用於注射器之匣盒、注射器及使用包括自動注射器及匣盒之設備之方法 |
| ES2973257T3 (es) | 2013-03-15 | 2024-06-19 | Amgen Inc | Casete de fármaco, autoinyector y sistema de autoinyector |
| AU2014228177B2 (en) | 2013-03-15 | 2018-04-26 | Amgen Inc. | Body contour adaptable autoinjector device |
| AU2014238267B2 (en) | 2013-03-22 | 2019-08-15 | Amgen Inc. | Injector and method of assembly |
| US9381246B2 (en) | 2013-09-09 | 2016-07-05 | Triact Therapeutics, Inc. | Cancer therapy |
| CN105873626A (zh) | 2013-10-24 | 2016-08-17 | 美国安进公司 | 注射器和组装方法 |
| WO2015061389A1 (fr) | 2013-10-24 | 2015-04-30 | Amgen Inc. | Système de distribution de médicaments équipé d'un dispositif de commande sensible à la température |
| CN110898312B (zh) * | 2013-12-20 | 2022-11-15 | 波士顿科学国际有限公司 | 集成导管系统 |
| WO2015119906A1 (fr) | 2014-02-05 | 2015-08-13 | Amgen Inc. | Système d'administration de médicament doté d'un générateur de champ électromagnétique |
| EP3139977B1 (fr) | 2014-05-07 | 2021-02-17 | Amgen Inc. | Auto-injecteur comprenant des éléments de réduction de choc |
| EP3151883A1 (fr) | 2014-06-03 | 2017-04-12 | Amgen Inc. | Dispositifs et procédés pour aider un utilisateur d'un dispositif d'administration de médicament |
| BR112016030291A2 (pt) | 2014-07-03 | 2017-11-14 | Imclone Llc | terapia de combinação |
| JP6480479B2 (ja) * | 2014-07-03 | 2019-03-13 | イムクローン リミテッド ライアビリティ カンパニー | Ｇｉｓｔの治療法 |
| AU2015332557B2 (en) | 2014-10-14 | 2020-05-14 | Amgen Inc. | Drug injection device with visual and audio indicators |
| GB201419084D0 (en) | 2014-10-27 | 2014-12-10 | Agency Science Tech & Res | Anti-PD-1 antibodies |
| GB201419094D0 (en) | 2014-10-27 | 2014-12-10 | Agency Science Tech & Res | Anti-TIM-3-antibodies |
| SG11201703403TA (en) | 2014-10-27 | 2017-05-30 | Agency Science Tech & Res | Anti-tim-3 antibodies |
| US10799630B2 (en) | 2014-12-19 | 2020-10-13 | Amgen Inc. | Drug delivery device with proximity sensor |
| JP2017538512A (ja) | 2014-12-19 | 2017-12-28 | アムジエン・インコーポレーテツド | ライブボタンまたはユーザインタフェースフィールドを含む薬物送達装置 |
| EP3556411B1 (fr) | 2015-02-17 | 2021-06-30 | Amgen Inc. | Dispositif d'administration de médicaments avec fixation et/ou de rétroaction assistée(s) sous vide |
| EP3981450A1 (fr) | 2015-02-27 | 2022-04-13 | Amgen, Inc | Dispositif d'administration de médicament ayant un mécanisme de protection d'aiguille présentant un seuil réglable de résistance au mouvement de l'élément de protection d'aiguille |
| WO2017039786A1 (fr) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Adaptateur d'ensemble de seringue pour une seringue |
| US11351308B2 (en) | 2015-12-09 | 2022-06-07 | Amgen Inc. | Auto-injector with signaling cap |
| KR102714544B1 (ko) | 2015-12-16 | 2024-10-10 | 리제너론 파마슈티칼스 인코포레이티드 | 단백질 극미립자를 제조하기 위한 조성물 및 방법 |
| US11154661B2 (en) | 2016-01-06 | 2021-10-26 | Amgen Inc. | Auto-injector with signaling electronics |
| US11200298B2 (en) | 2016-03-15 | 2021-12-14 | Amgen Inc. | Reducing probability of glass breakage in drug delivery devices |
| US11541168B2 (en) | 2016-04-29 | 2023-01-03 | Amgen Inc. | Drug delivery device with messaging label |
| US11389588B2 (en) | 2016-05-02 | 2022-07-19 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
| ES2959783T3 (es) | 2016-05-13 | 2024-02-28 | Amgen Inc | Conjunto de cubierta protectora de vial |
| US11238150B2 (en) | 2016-05-16 | 2022-02-01 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
| WO2017209899A1 (fr) | 2016-06-03 | 2017-12-07 | Amgen Inc. | Appareils et procédés d'essai au choc destinés aux dispositifs d'administration de médicaments |
| MA45493A (fr) * | 2016-06-27 | 2019-05-01 | Aicuris Anti Infective Cures Gmbh | Inhibiteurs d'entrée de hcmv. |
| US11285266B2 (en) | 2016-07-01 | 2022-03-29 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
| ES2822084T3 (es) | 2016-07-28 | 2021-04-29 | Elanco Us Inc | Anticuerpo antirreceptor alfa del factor de crecimiento derivado de plaquetas canino |
| WO2018034784A1 (fr) | 2016-08-17 | 2018-02-22 | Amgen Inc. | Dispositif d'administration de médicament avec détection de positionnement. |
| US20200261643A1 (en) | 2016-10-25 | 2020-08-20 | Amgen Inc. | On-body injector |
| MX2019008029A (es) | 2017-01-06 | 2019-12-11 | Abl Bio Inc | Anticuerpo anti-alfa-sinucleina y su uso. |
| AU2018210301A1 (en) | 2017-01-17 | 2019-08-01 | Amgen Inc. | Injection devices and related methods of use and assembly |
| JP7064501B2 (ja) | 2017-02-17 | 2022-05-10 | アムジエン・インコーポレーテツド | 無菌流体流路を備える薬物送達デバイスおよび関連する組立方法 |
| US11369736B2 (en) | 2017-02-17 | 2022-06-28 | Amgen Inc. | Cannula insertion and retraction mechanisms |
| AU2018231107B2 (en) | 2017-03-06 | 2023-04-20 | Amgen Inc. | Drug delivery device with activation prevention feature |
| CA3052482A1 (fr) | 2017-03-07 | 2018-09-13 | Amgen Inc. | Insertion d'aiguille par surpression |
| KR20240005194A (ko) | 2017-03-09 | 2024-01-11 | 암겐 인코포레이티드 | 약물 전달 장치용 삽입 메커니즘 |
| US20200071415A1 (en) | 2017-03-17 | 2020-03-05 | Imclone Llc | Combination therapy for pancreatic cancer |
| LT3600491T (lt) | 2017-03-28 | 2023-10-10 | Amgen Inc. | Stūmoklio koto ir švirkšto konstrukcinė sistema ir būdas |
| AU2018280054B2 (en) | 2017-06-08 | 2023-07-13 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
| WO2018226565A1 (fr) | 2017-06-08 | 2018-12-13 | Amgen Inc. | Dispositif d'administration de médicament entraîné par couple |
| US11541183B2 (en) | 2017-06-22 | 2023-01-03 | Amgen Inc. | Device activation impact/shock reduction |
| CA3063921A1 (fr) | 2017-06-23 | 2018-12-27 | Amgen Inc. | Dispositif electronique d'administration de medicament comprenant un bouchon active par un ensemble commutateur |
| MA49562A (fr) | 2017-07-14 | 2020-05-20 | Amgen Inc | Système d'insertion-rétractation d'aiguille présentant un système à ressort en double torsion |
| US11672733B2 (en) | 2017-07-21 | 2023-06-13 | Amgen Inc. | Gas permeable sealing member for drug container and methods of assembly |
| EP3658206A1 (fr) | 2017-07-25 | 2020-06-03 | Amgen Inc. | Dispositif d'administration de médicament doté d'un système d'accès à un récipient et procédé d'assemblage associé |
| EP3658203B1 (fr) | 2017-07-25 | 2022-08-31 | Amgen Inc. | Dispositif d'administration de médicament avec module d'engrenage et procédé d'assemblage associé |
| US20200164155A1 (en) | 2017-08-09 | 2020-05-28 | Amgen Inc. | Hydraulic-pneumatic pressurized chamber drug delivery system |
| EP3668567A1 (fr) | 2017-08-18 | 2020-06-24 | Amgen Inc. | Injecteur sur-corps avec patch adhésif stérile |
| US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
| WO2019070472A1 (fr) | 2017-10-04 | 2019-04-11 | Amgen Inc. | Adaptateur d'écoulement destiné à un dispositif d'administration de médicament |
| WO2019070497A1 (fr) | 2017-10-04 | 2019-04-11 | Imclone Llc | Polythérapie contre le cancer |
| US11813426B2 (en) | 2017-10-06 | 2023-11-14 | Amgen Inc. | Drug delivery device including seal member for needle of syringe |
| EP3694578A1 (fr) | 2017-10-09 | 2020-08-19 | Amgen Inc. | Dispositif d'administration de médicament comprenant un ensemble d'entraînement et procédé d'assemblage associé |
| MA50528A (fr) | 2017-11-03 | 2020-09-09 | Amgen Inc | Systèmes et approches pour stériliser un dispositif d'administration de médicament |
| MA50569A (fr) | 2017-11-06 | 2020-09-16 | Amgen Inc | Ensembles de remplissage-finition et procédés associés |
| AU2018358749B2 (en) | 2017-11-06 | 2024-02-29 | Amgen Inc. | Drug delivery device with placement and flow sensing |
| US11191904B2 (en) | 2017-11-10 | 2021-12-07 | Amgen Inc. | Plungers for drug delivery devices |
| JP7370969B2 (ja) | 2017-11-16 | 2023-10-30 | アムジエン・インコーポレーテツド | 薬物送達デバイスの扉ラッチ機構 |
| AU2018368338B2 (en) | 2017-11-16 | 2024-07-25 | Amgen Inc. | Autoinjector with stall and end point detection |
| WO2019117685A2 (fr) | 2017-12-14 | 2019-06-20 | 에이비엘바이오 주식회사 | Anticorps anti-igf1r et son utilisation |
| US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
| WO2019231803A1 (fr) | 2018-05-31 | 2019-12-05 | Imclone Llc | Polythérapie pour sarcome de tissu mou |
| US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
| US20210260279A1 (en) | 2018-07-24 | 2021-08-26 | Amgen Inc. | Hybrid drug delivery devices with optional grip portion and related method of preparation |
| WO2020023336A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs hybrides d'administration de médicament dotés d'une partie de préhension |
| WO2020023444A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs d'administration pour l'administration de médicaments |
| WO2020023451A1 (fr) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Dispositifs d'administration pour l'administration de médicaments |
| IL279323B1 (en) | 2018-07-31 | 2025-01-01 | Amgen Inc | Assembling a fluid pathway for a drug delivery device |
| WO2020068623A1 (fr) | 2018-09-24 | 2020-04-02 | Amgen Inc. | Systèmes et procédés de dosage interventionnel |
| EP3856283A1 (fr) | 2018-09-28 | 2021-08-04 | Amgen Inc. | Ensemble d'activation d'échappement de fil de muscle pour un dispositif d'administration de médicament |
| MA53815A (fr) | 2018-10-02 | 2022-01-05 | Amgen Inc | Systèmes d'injection pour administration de médicament avec transmission de force interne |
| MX2021003491A (es) | 2018-10-05 | 2021-06-18 | Amgen Inc | Dispositivo de administracion de farmacos con indicador de dosis. |
| US12053617B2 (en) | 2018-10-15 | 2024-08-06 | Amgen Inc. | Drug delivery device having damping mechanism |
| TWI846741B (zh) | 2018-10-15 | 2024-07-01 | 美商安進公司 | 用於藥物遞送裝置之平台組裝方法 |
| US11213620B2 (en) | 2018-11-01 | 2022-01-04 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
| IL281908B1 (en) | 2018-11-01 | 2025-02-01 | Amgen Inc | Drug delivery devices with partial drug delivery unit withdrawal |
| TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
| CA3119467A1 (fr) | 2018-11-20 | 2020-05-28 | Cornell University | Complexes macrocycliques de radionucleides et leur utilisation en radiotherapie du cancer |
| CN109134655B (zh) * | 2018-11-28 | 2019-02-26 | 上海复宏汉霖生物技术股份有限公司 | 一种抗PDGFRα的单克隆抗体及其制备方法和应用 |
| EP3958934A1 (fr) | 2019-04-24 | 2022-03-02 | Amgen Inc. | Ensembles et procédés de vérification de stérilisation de seringue |
| WO2021041067A2 (fr) | 2019-08-23 | 2021-03-04 | Amgen Inc. | Dispositif d'administration de médicament doté de composants configurables de mise en prise de protection d'aiguille et méthodes associées |
| JP7551744B2 (ja) | 2019-10-15 | 2024-09-17 | イーライ リリー アンド カンパニー | 組換え操作された、リパーゼ／エステラーゼ欠損哺乳動物細胞株 |
| WO2021118924A2 (fr) | 2019-12-12 | 2021-06-17 | Ting Therapeutics Llc | Compositions et méthodes de prévention et de traitement de la perte d'audition |
| MX2023013640A (es) | 2021-05-21 | 2023-11-30 | Amgen Inc | Metodo de optimizacion de una receta de llenado para un contenedor de medicamento. |
| WO2023081923A1 (fr) | 2021-11-08 | 2023-05-11 | Frequency Therapeutics, Inc. | Inhibiteurs du récepteur du facteur de croissance dérivé des plaquettes (pdgfr) alpha et leurs utilisations |
| WO2024207046A1 (fr) * | 2023-04-04 | 2024-10-10 | Telix Pharmaceuticals (Innovations) Pty Ltd | Réactifs et procédés d'imagerie de cancers exprimant pdgfralpha |
| WO2024207047A1 (fr) * | 2023-04-04 | 2024-10-10 | Telix Pharmaceuticals (Innovations) Pty Ltd | Méthodes de traitement de cancers exprimant pdgfr-alpha |
| WO2024207069A1 (fr) * | 2023-04-04 | 2024-10-10 | Telix Pharmaceuticals (Innovations) Pty Ltd | Réactifs et procédés d'imagerie de cancers exprimant pdgfralpha |
| WO2024207070A1 (fr) * | 2023-04-04 | 2024-10-10 | Telix Pharmaceuticals (Innovations) Pty Ltd | Méthodes de traitement de cancers exprimant pdgfralpha |
Family Cites Families (108)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5585344A (en) | 1984-03-19 | 1996-12-17 | The Rockefeller University | Liver-derived receptors for advanced glycosylation endproducts and uses thereof |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US4774321A (en) | 1986-12-01 | 1988-09-27 | Massachusetts Institute Of Technology | DP100 EGF and insulin-binding protein from Drosophila cells |
| WO1988007863A1 (fr) | 1987-04-06 | 1988-10-20 | Biogrowth, Inc. | Sous-unites de proteines porteuses de somatomedine humaine et leur procede de fabrication |
| US5200509A (en) | 1987-04-06 | 1993-04-06 | Celtrix Pharmaceuticals, Inc. | Human somatomedin carrier protein subunits and process for producing them; recombinant DNA molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| WO1989006692A1 (fr) | 1988-01-12 | 1989-07-27 | Genentech, Inc. | Procede de traitement de cellules tumorales par inhibition de la fonction receptrice du facteur de croissance |
| IL89489A0 (en) | 1988-03-09 | 1989-09-10 | Hybritech Inc | Chimeric antibodies directed against human carcinoembryonic antigen |
| AU631545B2 (en) | 1988-04-15 | 1992-12-03 | Protein Design Labs, Inc. | Il-2 receptor-specific chimeric antibodies |
| CA1341411C (fr) | 1988-04-16 | 2002-12-17 | Lutz Riechmann | Procede de production de fragments fv dans les cellules eucaryotes |
| AU4128089A (en) | 1988-09-15 | 1990-03-22 | Rorer International (Overseas) Inc. | Monoclonal antibodies specific to human epidermal growth factor receptor and therapeutic methods employing same |
| GB8826451D0 (en) | 1988-11-11 | 1988-12-14 | Sandoz Ltd | Improvements in/relating to organic compounds |
| US5571714A (en) | 1988-12-22 | 1996-11-05 | Celtrix Pharmaceuticals, Inc. | Monoclonal antibodies which bind both transforming growth factors β1 and β2 and methods of use |
| IL92816A0 (en) | 1988-12-22 | 1990-09-17 | Biogrowth Inc | Recombinant dna molecules,hosts,processes and human somatomedin carrier protein-like polypeptides |
| ATE179457T1 (de) | 1989-02-09 | 1999-05-15 | Us Health | Zuwachsfaktorrezeptorgen deriviert von platten des typs oc |
| US6228600B1 (en) | 1992-07-20 | 2001-05-08 | The United States Of America As Represented By The Department Of Health And Human Services | Immunoassays for the alpha platelet-derived growth factor receptor |
| US5468468A (en) | 1989-02-09 | 1995-11-21 | The United States Of America, As Represented By The Secretary Of The Department Of Health & Human Services | Method for making a monoclonal antibody, monoclonal antibodies to α PD |
| US7252929B2 (en) | 1989-02-09 | 2007-08-07 | United States Of America, As Represented By The Secretary, Dept Of Health & Human Services | Methods for identifying alpha PDGFR agonists and antagonists |
| US5705157A (en) | 1989-07-27 | 1998-01-06 | The Trustees Of The University Of Pennsylvania | Methods of treating cancerous cells with anti-receptor antibodies |
| US5977307A (en) | 1989-09-07 | 1999-11-02 | Alkermes, Inc. | Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| IL97872A (en) | 1990-04-16 | 1996-07-23 | Rhone Poulenc Rorer Int | Pharmaceutical compositions containing styryl-substituted monocylic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase and a compounds of this type |
| US5196446A (en) | 1990-04-16 | 1993-03-23 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Certain indole compounds which inhibit EGF receptor tyrosine kinase |
| CA2090703A1 (fr) | 1990-08-28 | 1992-03-01 | Michael C. Kiefer | Proteine (igfbp-4) possedant une forte affinite pour un facteur de croissance de substances apparentees a l'insuline |
| ATE193553T1 (de) | 1991-01-31 | 2000-06-15 | Cor Therapeutics Inc | Domänen von extrazellulären bereichen von menschlichen blutplättchen abstammenden wachstumsfaktor rezeptor-polypeptiden |
| GB9300059D0 (en) | 1992-01-20 | 1993-03-03 | Zeneca Ltd | Quinazoline derivatives |
| US5262308A (en) | 1992-01-28 | 1993-11-16 | Thomas Jefferson University | Cell lines which constitutively express IGF-1 and IGF-1 R |
| AU4025193A (en) | 1992-04-08 | 1993-11-18 | Cetus Oncology Corporation | Humanized C-erbB-2 specific antibodies |
| US5597563A (en) | 1992-09-04 | 1997-01-28 | Beschorner; William E. | Method induction of antigen-specific immune tolerance |
| US5869337A (en) | 1993-02-12 | 1999-02-09 | President And Fellows Of Harvard College | Regulated transcription of targeted genes and other biological events |
| DK0686044T3 (da) | 1993-02-25 | 2000-10-09 | Zymogenetics Inc | Hæmning af intimal hyperplasi under anvendelse af antistoffer mod PDGF-receptorer |
| US5620687A (en) | 1993-02-25 | 1997-04-15 | Zymogenetics, Inc. | Inhibition of intimal hyperplasia using antibodies to PDGF beta receptors |
| US5976534A (en) | 1993-02-25 | 1999-11-02 | Zymogenetics, Inc. | Inhibition of intimal hyperplasia using antibodies to PDGF receptors and heparin |
| JPH08508409A (ja) | 1993-04-06 | 1996-09-10 | シーダーズ − サイナイ メディカル センター | 変異インスリン様増殖因子▲ｉ▼受容体サブユニットおよびそれらの使用方法 |
| EP0739488A1 (fr) | 1994-01-14 | 1996-10-30 | Genentech, Inc. | Antagonistes de l'inhibiteur de l'activite tyrosine kinase du recepteur de l'insuline |
| US5654307A (en) | 1994-01-25 | 1997-08-05 | Warner-Lambert Company | Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| US5532159A (en) | 1994-04-01 | 1996-07-02 | The Ohio State University | Monoclonal antibody to canine placental oncofetal protein for detecting cancer |
| US5597700A (en) | 1994-04-28 | 1997-01-28 | California Research, Llc | Method for detecting free insulin-like growth-factor-binding protein 1 and a test device for detecting the ruptures of fetal membranes using the above method |
| ES2150573T3 (es) | 1994-06-24 | 2000-12-01 | Vladimir P Torchilin | Composicion que contiene autoanticuerpos para la terapia y profilaxis tumorales. |
| US5939269A (en) | 1994-12-28 | 1999-08-17 | The Regents Of The University Of California | Antagonists to insulin receptor tyrosine kinase inhibitor |
| EP1110953B1 (fr) | 1995-03-30 | 2009-10-28 | Pfizer Products Inc. | Dérivés de quinazolinone |
| GB9508538D0 (en) | 1995-04-27 | 1995-06-14 | Zeneca Ltd | Quinazoline derivatives |
| JP2000500654A (ja) | 1995-11-14 | 2000-01-25 | トーマス・ジェファーソン・ユニバーシティ | 可溶性ｉｇｆ−１受容体による腫瘍成長に対する誘導耐性 |
| AU1441497A (en) | 1996-01-23 | 1997-08-20 | Novartis Ag | Pyrrolopyrimidines and processes for their preparation |
| GB9603095D0 (en) | 1996-02-14 | 1996-04-10 | Zeneca Ltd | Quinazoline derivatives |
| GB9707800D0 (en) | 1996-05-06 | 1997-06-04 | Zeneca Ltd | Chemical compounds |
| AUPN999096A0 (en) | 1996-05-22 | 1996-06-13 | Northstar Biologicals Pty Ltd | Peptides, antibodies, vaccines & uses thereof |
| DE69734513T2 (de) | 1996-06-24 | 2006-07-27 | Pfizer Inc. | Phenylamino-substituierte tricyclische derivate zur behandlung hyperproliferativer krankheiten |
| US5798266A (en) | 1996-08-27 | 1998-08-25 | K-Quay Enterprises, Llc | Methods and kits for obtaining and assaying mammary fluid samples for breast diseases, including cancer |
| US6071891A (en) | 1996-11-22 | 2000-06-06 | Regents Of The University Of Minnesota | Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells composition |
| BR9807305A (pt) | 1997-02-05 | 2000-05-02 | Warner Lambert Co | Pirido [2,3-d] pirimidinas e 4-aminopirimidinas como inibidores de proliferação celular. |
| BR9910511A (pt) | 1998-05-15 | 2001-11-20 | Imclone Systems Inc | Tratamento de tumores humanos com radiação einibidores de tirosina cinases receptoras de fatorde crescimento |
| ZA200007412B (en) | 1998-05-15 | 2002-03-12 | Imclone Systems Inc | Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases. |
| US6875741B2 (en) | 1998-09-02 | 2005-04-05 | Renuka Pillutla | Insulin and IGF-1 receptor agonists and antagonists |
| WO2000018761A1 (fr) | 1998-09-29 | 2000-04-06 | American Cyanamid Company | Inhibiteurs de proteines de type tyrosine kinases a base de 3-cyanoquinolines substituees |
| EA003634B1 (ru) | 1998-10-05 | 2003-08-28 | Фармэкса А/С | Новые способы терапевтической вакцинации |
| ES2188254T3 (es) | 1998-11-19 | 2003-06-16 | Warner Lambert Co | N-(4-(3-chloro-4-fluoro-fenilamino)-7-(3-morfolin-4-il-propoxi)-quin azolin-6-il)-acrilamada, un inhibidor irreversible de tirosina quinasas. |
| EP1006184A1 (fr) | 1998-12-03 | 2000-06-07 | F. Hoffmann-La Roche Ag | Protéines interagissant avec le récepteur de IGF-1, gènes codant pour ces protéines et leurs utilisations |
| US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
| EP1202686A1 (fr) | 1999-07-27 | 2002-05-08 | Michael Miravet Sorribes | Dispositif permettant de corriger la forme de l'oreille externe humaine de fa on non invasive |
| JP2004511430A (ja) | 2000-05-24 | 2004-04-15 | イムクローン システムズ インコーポレイティド | 二重特異性免疫グロブリン様抗原結合蛋白および製造方法 |
| RU2183461C2 (ru) * | 2000-05-29 | 2002-06-20 | Ростовский научно-исследовательский онкологический институт МЗ РФ | Способ лечения сарком мягких тканей |
| US7329745B2 (en) | 2000-06-13 | 2008-02-12 | City Of Hope | Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth |
| US20030165502A1 (en) | 2000-06-13 | 2003-09-04 | City Of Hope | Single-chain antibodies against human insulin-like growth factor I receptor: expression, purification, and effect on tumor growth |
| AU2001274536A1 (en) | 2000-06-15 | 2002-01-02 | Kyowa Hakko Kogyo Co. Ltd. | Insulin-like growth factor-binding protein |
| US8153121B2 (en) | 2000-10-06 | 2012-04-10 | Los Angeles Biomedical Research Institute at Harbor—UCLA Medical Center | Diagnosis and therapy of antibody-mediated inflammatory autoimmune disorders |
| EP2194067B1 (fr) | 2001-01-05 | 2017-12-06 | Pfizer Inc. | Anticorps anti-récepteur de croissance I analogue à l'insuline (IGF-IR) |
| AU2002248609B2 (en) | 2001-03-14 | 2007-03-01 | Genentech, Inc. | IGF antagonist peptides |
| US20040116330A1 (en) | 2001-04-27 | 2004-06-17 | Kenichiro Naito | Preventive/therapeutic method for cancer |
| US7135174B2 (en) * | 2002-01-07 | 2006-11-14 | Amgen Fremont, Inc. | Antibodies directed to PDGFD and uses thereof |
| US7241444B2 (en) * | 2002-01-18 | 2007-07-10 | Pierre Fabre Medicament | Anti-IGF-IR antibodies and uses thereof |
| DE60312639T2 (de) | 2002-01-18 | 2007-11-29 | Pierre Fabre Médicament | Antikörper gegen igf-ir und ihre verwendungen |
| US7553485B2 (en) | 2002-01-18 | 2009-06-30 | Pierre Fabre Medicament | Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof |
| SI1916001T1 (sl) | 2002-03-04 | 2011-10-28 | Imclone Llc | Äśloveĺ ka protitelesa specifiäśna za kdr in njihova uporaba |
| NZ536475A (en) | 2002-05-24 | 2008-06-30 | Schering Corp | Neutralizing human anti-igfr antibody |
| US8034904B2 (en) | 2002-06-14 | 2011-10-11 | Immunogen Inc. | Anti-IGF-I receptor antibody |
| US7538195B2 (en) * | 2002-06-14 | 2009-05-26 | Immunogen Inc. | Anti-IGF-I receptor antibody |
| PT1517921E (pt) | 2002-06-28 | 2006-09-29 | Domantis Ltd | Ligandos duplamente especificos com semi-vida no soro aumentada |
| EP1546203B1 (fr) | 2002-08-01 | 2012-06-20 | Immunomedics, Inc. | Anticorps anti-alpha-fetoproteine immu31, proteines de fusion et procedes d'utilisation de ceux-ci |
| US20040102360A1 (en) | 2002-10-30 | 2004-05-27 | Barnett Stanley F. | Combination therapy |
| AU2004212344B2 (en) | 2003-02-13 | 2009-05-07 | Pfizer Products Inc. | Uses of anti-insulin-like growth factor I receptor antibodies |
| BRPI0408317A (pt) | 2003-03-14 | 2006-03-07 | Pharmacia Corp | anticorpos do receptor de igf-i para o tratamento de cáncer |
| WO2004087756A2 (fr) | 2003-04-02 | 2004-10-14 | F. Hoffmann-La Roche Ag | Anticorps contre le recepteur du facteur de croissance 1 analogue a l'insuline et utilisations de ceux-ci |
| WO2005016970A2 (fr) | 2003-05-01 | 2005-02-24 | Imclone Systems Incorporated | Anticorps entierement humains diriges contre le recepteur du facteur de croissance 1 de type insuline |
| RU2241452C1 (ru) * | 2003-06-11 | 2004-12-10 | Московский областной научно-исследовательский клинический институт | Способ лечения метастазов в кости |
| AR046071A1 (es) | 2003-07-10 | 2005-11-23 | Hoffmann La Roche | Anticuerpos contra el receptor i del factor de crecimiento de tipo insulinico y los usos de los mismos |
| US20050079184A1 (en) | 2003-08-08 | 2005-04-14 | Immunomedics, Inc. | Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| AP2006003510A0 (en) | 2003-08-13 | 2006-02-28 | Pfizer Prod Inc | Modified human IGF-1R antibodies. |
| WO2005018671A1 (fr) | 2003-08-21 | 2005-03-03 | Kyowa Hakko Kogyo Co., Ltd. | Inhibiteur de metastase cancereuse |
| CA2540133A1 (fr) | 2003-09-24 | 2005-03-31 | Kyowa Hakko Kogyo Co., Ltd. | Medicaments pour le traitement du cancer |
| AR046639A1 (es) | 2003-11-21 | 2005-12-14 | Schering Corp | Combinaciones terapeuticas de anticuerpo anti- igfr1 |
| JP2007523956A (ja) | 2004-02-25 | 2007-08-23 | ダナ−ファーバー キャンサー インスティテュート インク． | 腫瘍細胞増殖を阻害するための方法 |
| DE602005027673D1 (de) * | 2004-03-05 | 2011-06-09 | Vegenics Pty Ltd | Materialien und verfahren für wachstumsfaktorbindende konstrukte |
| JP4493485B2 (ja) | 2004-04-28 | 2010-06-30 | シャープ株式会社 | 太陽電池モジュール用配線部材、それを用いた太陽電池モジュールおよび太陽電池モジュール用配線部材の製造方法 |
| EP2322217A3 (fr) | 2004-07-16 | 2011-09-28 | Pfizer Products Inc. | Traitement combiné pour malignités non hematologiques par anticorps anti-IGF-1R |
| EP1786918A4 (fr) | 2004-07-17 | 2009-02-11 | Imclone Systems Inc | Nouveau anticorps bispecifique tetravalent |
| FR2873699B1 (fr) | 2004-07-29 | 2009-08-21 | Pierre Fabre Medicament Sa | Nouveaux anticorps anti igf ir rt leurs utilisations |
| US7811562B2 (en) | 2004-12-03 | 2010-10-12 | Schering Corporation | Biomarkers for pre-selection of patients for anti-IGF1R therapy |
| US20060134172A1 (en) | 2004-12-21 | 2006-06-22 | Alcon, Inc. | Agents which regulate, inhibit, or modulate the activity and/or expression of lysyl oxidase (LOX) and LOX-like proteases as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies |
| MY146381A (en) | 2004-12-22 | 2012-08-15 | Amgen Inc | Compositions and methods relating relating to anti-igf-1 receptor antibodies |
| CA2618721A1 (fr) | 2005-04-15 | 2006-10-26 | Immunogen, Inc. | Elimination d'une population de cellules heterogenes ou mixtes dans des tumeurs |
| KR101246428B1 (ko) * | 2005-06-17 | 2013-03-21 | 필라델피아 헬스 앤드 에듀케이션 코포레이션 디/비/에이 드렉셀 유니버시티 컬리지 오브 메디슨 | 항－ＰＤＧＦＲα 항체를 이용하여 이차 골 종양을 치료하는 방법 |
| WO2007000328A1 (fr) | 2005-06-27 | 2007-01-04 | Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa | Anticorps se fixant à un épitope sur un récepteur de facteur de croissance insulinomimétique de type 1 et leurs utilisations |
| US20070009970A1 (en) | 2005-07-08 | 2007-01-11 | Predicant Biosciences, Inc. | Biological patterns for diagnosis and treatment of cancer |
| FR2888850B1 (fr) | 2005-07-22 | 2013-01-11 | Pf Medicament | Nouveaux anticorps anti-igf-ir et leurs applications |
| TWI478940B (zh) | 2005-08-26 | 2015-04-01 | Roche Glycart Ag | 具有經改變細胞傳訊活性之改質抗原結合分子 |
| BRPI0619786A2 (pt) | 2005-12-13 | 2011-10-18 | Astrazeneca Ab | proteìna de ligação especìfica, molécula de ácido nucleico, vetor, célula hospedeira, anticorpo monoclonal humano, método para determinar o nìvel de fator de crescimento tipo insulina-ii (igf-1i) e fator de crescimento tipo insulina i (igf-1) em uma amostra de paciente, uso da proteìna de ligação especìfica, e, conjugado |
| WO2010000008A1 (fr) | 2008-06-30 | 2010-01-07 | Desi Raymond Richardson | Composés thiosemicarbazones et leur utilisation |
| CA2725512C (fr) | 2008-07-18 | 2016-06-28 | F. Hoffmann-La Roche Ag | Nouvelles phenylimidazopyrazines |
| DK200900548A (en) | 2008-07-18 | 2010-01-19 | Univ Koebenhavn | Processes for manufacture of products from plants |
-
2006
- 2006-06-19 KR KR1020097003170A patent/KR101246428B1/ko active IP Right Grant
- 2006-06-19 EP EP09075103.3A patent/EP2100614B8/fr active Active
- 2006-06-19 KR KR1020097003171A patent/KR101246504B1/ko active Protection Beyond IP Right Term
- 2006-06-19 BR BRPI0622073A patent/BRPI0622073A8/pt not_active Application Discontinuation
- 2006-06-19 PL PL09075102T patent/PL2100618T3/pl unknown
- 2006-06-19 RU RU2008101772/14A patent/RU2008101772A/ru not_active Application Discontinuation
- 2006-06-19 PT PT90751033T patent/PT2100614E/pt unknown
- 2006-06-19 CA CA002612449A patent/CA2612449A1/fr not_active Abandoned
- 2006-06-19 CN CN200910126431.1A patent/CN101613409B/zh active Active
- 2006-06-19 PL PL09075103T patent/PL2100614T3/pl unknown
- 2006-06-19 PT PT90751025T patent/PT2100618E/pt unknown
- 2006-06-19 DK DK09075103.3T patent/DK2100614T3/da active
- 2006-06-19 SI SI200631722T patent/SI2100614T1/sl unknown
- 2006-06-19 CN CN2009101264326A patent/CN101612399B/zh not_active Expired - Fee Related
- 2006-06-19 CA CA2680945A patent/CA2680945C/fr active Active
- 2006-06-19 SI SI200631744T patent/SI2100618T1/sl unknown
- 2006-06-19 US US11/917,890 patent/US8128929B2/en active Active
- 2006-06-19 JP JP2008517219A patent/JP2009501141A/ja active Pending
- 2006-06-19 EP EP12162951A patent/EP2505205A1/fr not_active Withdrawn
- 2006-06-19 DK DK09075102.5T patent/DK2100618T3/en active
- 2006-06-19 CN CNA2006800284670A patent/CN101500597A/zh active Pending
- 2006-06-19 ES ES09075103T patent/ES2435727T3/es active Active
- 2006-06-19 EP EP06785127A patent/EP1909819A4/fr not_active Withdrawn
- 2006-06-19 WO PCT/US2006/023856 patent/WO2006138729A2/fr active Application Filing
- 2006-06-19 KR KR1020087001415A patent/KR20080047529A/ko not_active Application Discontinuation
- 2006-06-19 CA CA2678008A patent/CA2678008C/fr not_active Expired - Fee Related
- 2006-06-19 EP EP09075102.5A patent/EP2100618B1/fr active Active
- 2006-06-19 BR BRPI0611984-0A patent/BRPI0611984A2/pt not_active IP Right Cessation
- 2006-06-19 ES ES09075102.5T patent/ES2452115T3/es active Active
- 2006-06-19 RU RU2009115364/15A patent/RU2502523C2/ru not_active IP Right Cessation
-
2007
- 2007-12-16 IL IL188151A patent/IL188151A0/en unknown
-
2008
- 2008-07-28 HK HK10102590.8A patent/HK1135917A1/xx unknown
-
2009
- 2009-02-17 JP JP2009033512A patent/JP5154470B2/ja not_active Expired - Fee Related
- 2009-02-17 JP JP2009033517A patent/JP5436883B2/ja active Active
- 2009-04-22 RU RU2009115363A patent/RU2455026C3/ru active Protection Beyond IP Right Term
- 2009-05-21 IL IL198869A patent/IL198869A/en not_active IP Right Cessation
- 2009-05-21 IL IL198870A patent/IL198870A/en active Protection Beyond IP Right Term
-
2011
- 2011-10-19 US US13/276,353 patent/US8574578B2/en active Active
- 2011-10-19 US US13/276,358 patent/US8425911B2/en not_active Expired - Fee Related
-
2012
- 2012-06-13 JP JP2012134040A patent/JP2012179060A/ja active Pending
-
2013
- 2013-11-14 CY CY20131101013T patent/CY1114603T1/el unknown
-
2014
- 2014-04-04 CY CY20141100261T patent/CY1115076T1/el unknown
-
2017
- 2017-04-05 LU LU00012C patent/LUC00012I2/fr unknown
- 2017-04-05 CY CY2017013C patent/CY2017013I1/el unknown
- 2017-04-14 NL NL300869C patent/NL300869I2/nl unknown
- 2017-04-18 LT LTPA2017011C patent/LTC2100614I2/lt unknown
- 2017-04-18 HU HUS1700015C patent/HUS1700015I1/hu unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR20C1014I1 (fr) | ||
| LUC00012I2 (fr) | ||
| BE2012C042I2 (fr) | ||
| BRPI0601358B8 (pt) | Aplicador de clipe cirúrgico | |
| BRPI0601402B8 (pt) | Aplicador de grampos cirúrgicos | |
| BR122017004707A2 (fr) | ||
| BRPI0609157A8 (fr) | ||
| BRPI0608519A2 (fr) | ||
| BR122020005056A2 (fr) | ||
| AP2140A (fr) | ||
| BR122016029989A2 (fr) | ||
| BRPI0604219A (fr) | ||
| JP2006345169A5 (fr) | ||
| BRPI0618215B8 (fr) | ||
| JP2007020026A5 (fr) | ||
| JP2007054000A5 (fr) | ||
| JP2007005364A5 (fr) | ||
| JP2006035317A5 (fr) | ||
| BY2237U (fr) | ||
| CN105122969C (fr) | ||
| CN300725996S (zh) | 鞋帮 | |
| CN300726004S (zh) | 鞋帮 | |
| CN300726016S (zh) | 鞋帮 | |
| CN300726015S (zh) | 鞋底 | |
| CN300725995S (zh) | 鞋帮 |